SRRK
NASDAQ · Biotechnology
Scholar Rock Holding Corp
$42.30
-1.36 (-3.12%)
Performance
1D
—
1W
—
1M
—
3M
-7.38%
6M
+9.16%
1Y
+27.10%
YTD
-1.17%
Open$42.85
Previous Close$43.66
Day High$43.20
Day Low$40.20
52W High$49.82
52W Low$22.71
Volume—
Avg Volume1.35M
Market Cap5.23B
P/E Ratio—
EPS$-3.30
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$45.16
Below
SMA 200
$36.91
Above
RSI (14)
59.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
+68.5% upside
Current
$42.30
$42.30
Target
$71.29
$71.29
$54.07
$71.29 avg
$91.55
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 910.50M | 880.80M | 846.68M |
| Net Income | -11,497,538 | -12,296,426 | -11,692,649 |
| Profit Margin | -1.3% | -1.4% | -1.4% |
| EBITDA | -11,509,292 | -12,212,052 | -11,111,961 |
| Free Cash Flow | -10,999,659 | -14,100,591 | -9,156,076 |
| Rev Growth | +11.0% | +3.4% | +15.4% |
| Debt/Equity | 0.75 | 0.83 | 0.78 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |